Inogen Management
Management criteria checks 0/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Key information
Kevin R. Smith
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target
Mar 01
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%
Feb 01Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?
Oct 06Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business
Jun 21Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?
Mar 14Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth
Oct 27Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price
Sep 20Inogen: Structural, Supply Chain Headwinds Remain
Sep 13Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M
Aug 04Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds
Jun 14At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?
Apr 03Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story
Mar 31Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?
Mar 09Inogen: Capacity Constraints Cloud Post Pandemic Potential
Jan 06Is Inogen, Inc. (NASDAQ:INGN) Potentially Undervalued?
Dec 09Returns On Capital At Inogen (NASDAQ:INGN) Paint A Concerning Picture
Nov 08Supply Chain Issues Knock Inogen Back, But Underlying Growth Is Encouraging
Aug 30Inogen names Stanislav Glezer as chief medical officer
Jun 08Inogen, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06CEO
Kevin R. Smith (52 yo)
less than a year
Tenure
Mr. Kevin R. M. Smith serves as President, CEO and Director at Inogen Inc. since November 13, 2023. He served as Director at OncoSec Medical Incorporated since February 7, 2020 until June 14, 2023 and serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP | 2.8yrs | US$1.26m | 0.028% $ 40.9k | |
| Executive VP of R&D and Chief Medical Officer | less than a year | US$2.54m | 0.069% $ 101.5k | |
| President | less than a year | no data | no data | |
| Executive VP | less than a year | no data | no data | |
| Senior Vice President of Operations & Supply Chain | 1.2yrs | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.9yrs | no data | no data | |
| Senior Vice President of Enterprise Enablement | 1.7yrs | no data | no data | |
| Executive VP & Chief Commercial Officer | less than a year | no data | no data |
0.8yrs
Average Tenure
53yo
Average Age
Erfahrenes Management: INGNDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.5 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 2.1yrs | US$258.43k | 0.031% $ 46.0k | |
| Independent Director | 2.1yrs | US$264.24k | 0.031% $ 46.0k | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Board Chairperson | 2.9yrs | US$316.12k | 0.041% $ 60.5k | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | 0.0073% $ 10.8k | |
| Independent Director | 9.7yrs | US$244.10k | 0.088% $ 129.9k | |
| Independent Director | 2.1yrs | US$263.93k | 0.031% $ 46.0k |
2.1yrs
Average Tenure
61yo
Average Age
Erfahrener Vorstand: INGNDie Vorstandsmitglieder gelten nicht als erfahren ( 1.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.